IPRIPR2023-00999Terminated-Settled
Samsung Bioepis Co., Ltd.v.Alexion Pharmaceuticals, Inc. et al.
IPR challenge of US 9725504.
Type
IPR
Filed
May 31, 2023
Instituted
Dec 8, 2023
Decided
Sep 4, 2024
Patent
Application
15260888
Inventor
Leonard BELL et al
Granted
Aug 8, 2017
01
Timeline
3 milestones
2023-05-31Petition filed
2023-12-08Institution
2024-09-04Terminated
02
Parties & counsel
Petitioner
Samsung Bioepis Co., Ltd.
Counsel
Rhyu, Michelleet al
Patent Owner
Alexion Pharmaceuticals, Inc. et al.
Counsel
Flattmann, Geraldet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →